METTL3 and urinary bladder cancer: METTL3 can downregulate PTEN expression by interacting with the microprocessor protein DGCR8 and positively regulating pri-miR221/222 processing in an m6A-dependent manner, thus exerting oncogenic effects in bladder cancer [92].